Stericycle (NASDAQ:SRCL)‘s stock had its “hold” rating restated by research analysts at Oppenheimer in a research note issued to investors on Wednesday.

Other equities analysts have also issued research reports about the company. Jefferies Group set a $83.00 target price on Stericycle and gave the company a “buy” rating in a research note on Wednesday. William Blair reissued an “ourperform” rating on shares of Stericycle in a research note on Thursday, September 14th. Royal Bank of Canada cut their target price on Stericycle from $74.00 to $67.00 and set an “underperform” rating on the stock in a research note on Thursday, November 9th. BMO Capital Markets cut their target price on Stericycle from $74.00 to $62.00 and set a “market perform” rating on the stock in a research note on Friday, November 10th. Finally, BidaskClub raised Stericycle from a “strong sell” rating to a “sell” rating in a research note on Saturday, December 2nd. Four research analysts have rated the stock with a sell rating, four have assigned a hold rating and six have issued a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus price target of $74.45.

Stericycle (SRCL) traded up $0.13 during trading hours on Wednesday, reaching $67.30. The company’s stock had a trading volume of 709,100 shares, compared to its average volume of 825,601. Stericycle has a 1 year low of $61.25 and a 1 year high of $88.00. The company has a quick ratio of 0.82, a current ratio of 0.82 and a debt-to-equity ratio of 0.93. The firm has a market capitalization of $5,734.50, a price-to-earnings ratio of 15.48, a price-to-earnings-growth ratio of 1.64 and a beta of 0.16.

Stericycle (NASDAQ:SRCL) last released its earnings results on Wednesday, November 8th. The business services provider reported $1.10 earnings per share for the quarter, missing the consensus estimate of $1.14 by ($0.04). Stericycle had a negative net margin of 0.79% and a positive return on equity of 13.93%. The company had revenue of $883.00 million during the quarter, compared to analyst estimates of $896.81 million. During the same period in the previous year, the company posted $1.24 EPS. The company’s quarterly revenue was down .8% compared to the same quarter last year. sell-side analysts expect that Stericycle will post 4.5 EPS for the current year.

In other news, Director Mark C. Miller sold 19,753 shares of the firm’s stock in a transaction dated Monday, November 13th. The stock was sold at an average price of $64.03, for a total transaction of $1,264,784.59. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. In the last ninety days, insiders have sold 79,012 shares of company stock worth $5,240,668. 3.50% of the stock is currently owned by insiders.

A number of institutional investors have recently made changes to their positions in SRCL. Jennison Associates raised its position in Stericycle by 10.5% in the 3rd quarter. Jennison Associates now owns 1,310,847 shares of the business services provider’s stock valued at $182,614,000 after buying an additional 124,485 shares during the last quarter. Eagle Asset Management grew its stake in Stericycle by 104.4% in the third quarter. Eagle Asset Management now owns 100,836 shares of the business services provider’s stock valued at $14,046,000 after purchasing an additional 51,504 shares in the last quarter. MUFG Americas grew its stake in Stericycle by 8.3% in the third quarter. MUFG Americas now owns 40,674 shares of the business services provider’s stock valued at $5,667,000 after purchasing an additional 3,109 shares in the last quarter. Bath Savings Trust Company grew its stake in Stericycle by 0.8% in the fourth quarter. Bath Savings Trust Company now owns 52,970 shares of the business services provider’s stock valued at $6,388,000 after purchasing an additional 405 shares in the last quarter. Finally, West Oak Capital grew its stake in Stericycle by 17.6% in the fourth quarter. West Oak Capital now owns 11,510 shares of the business services provider’s stock valued at $1,388,106 after purchasing an additional 1,720 shares in the last quarter. 94.63% of the stock is currently owned by institutional investors and hedge funds.

TRADEMARK VIOLATION WARNING: “Oppenheimer Reaffirms “Hold” Rating for Stericycle (SRCL)” was published by American Banking News and is the property of of American Banking News. If you are reading this piece of content on another domain, it was illegally copied and republished in violation of international copyright & trademark law. The legal version of this piece of content can be read at https://www.americanbankingnews.com/2017/12/13/oppenheimer-reaffirms-hold-rating-for-stericycle-srcl.html.

About Stericycle

Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.

Analyst Recommendations for Stericycle (NASDAQ:SRCL)

Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.